MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
8.66
+0.57
+7.05%
After Hours: 8.66 0 0.00% 17:33 03/31 EDT
OPEN
8.28
PREV CLOSE
8.09
HIGH
8.85
LOW
8.28
VOLUME
1.53M
TURNOVER
--
52 WEEK HIGH
9.73
52 WEEK LOW
4.550
MARKET CAP
702.51M
P/E (TTM)
-4.1062
1D
5D
1M
3M
1Y
5Y
1D
MeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
TipRanks · 1d ago
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall St · 1d ago
Weekly Report: what happened at MGTX last week (0323-0327)?
Weekly Report · 1d ago
MeiraGTx Holdings Price Target Cut to $26.00/Share From $30.00 by Piper Sandler
Dow Jones · 4d ago
MeiraGTx Holdings Is Maintained at Overweight by Piper Sandler
Dow Jones · 4d ago
Piper Sandler Maintains Overweight on MeiraGTx Hldgs, Lowers Price Target to $26
Benzinga · 4d ago
MeiraGTx Holdings Price Target Raised to $16.00/Share From $14.00 by B of A Securities
Dow Jones · 4d ago
MeiraGTx Holdings Is Maintained at Buy by B of A Securities
Dow Jones · 4d ago
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.